MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Amgen EV/EBITDA Ratio 2011-2026 | AMGN
Annual EV/EBITDA Ratio Amgen
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.7 | 13.2 | 13.5 | 12.2 | 14.4 | 12.3 | 13.5 | 17.2 | 16.7 | 15.2 | 13.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.2 | 10.7 | 13.9 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
9.24 | $ 3.56 | - | $ 1.06 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
-3.79 | $ 3.13 | - | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
ADC Therapeutics SA
ADCT
|
-4.34 | $ 4.22 | - | $ 105 M | Schweiz |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.79 | 0.01 % | $ 4.31 M | China |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
argenx SE
ARGX
|
-39.4 | $ 703.3 | - | $ 25 B |  Niderland |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 231.03 | 2.23 % | $ 5 B |  Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.61 | - | $ 8.69 B |  Australia |
 |
Atea Pharmaceuticals
AVIR
|
-0.282 | $ 6.05 | - | $ 493 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-2.37 | $ 6.63 | - | $ 182 M |  Israel |
 |
BioCardia
BCDA
|
-0.747 | $ 1.27 | - | $ 26.9 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Athersys
ATHX
|
0.437 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.34 | $ 11.58 | - | $ 1.03 B | USA |
 |
Cerus Corporation
CERS
|
-24.7 | $ 1.8 | 6.51 % | $ 343 M | USA |
 |
Anika Therapeutics
ANIK
|
38.7 | $ 14.36 | - | $ 210 M | USA |
 |
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | USA |
 |
BioNTech SE
BNTX
|
4.1 | $ 90.54 | - | $ 27.2 B | Germany |
 |
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
-1.76 | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | Israel |
 |
CNS Pharmaceuticals
CNSP
|
0.205 | $ 2.45 | 0.41 % | $ 936 K | USA |
 |
Aytu BioScience
AYTU
|
-1.92 | $ 2.64 | - | $ 16.6 M | USA |
 |
Cardiff Oncology
CRDF
|
-8.15 | $ 1.9 | - | $ 127 M | USA |
 |
CorMedix
CRMD
|
-3.52 | $ 6.54 | - | $ 471 K | USA |
 |
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.51 | - | $ 385 M | Britain |